Clinical Trials Browser

OTHER × romiplostim × Plasma cell × Clear all

NCT04478123 2024-02-14

Using Romiplostim to Treat Low Platelet Counts Following Chemotherapy and Autologous Hematopoietic Cell Transplantation in People With Blood Cancer

Phase 2 Completed

62 enrolled 7 charts

Classical hematologyLymphoidPlasma cell

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Thrombocytopenia

NCT02046291 2021-06-08

Safety of Romiplostim (Nplate®) Following UCBT

Phase 1 Completed

LymphoidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Leukemia, Lymphoid, Leukemia, Monocytic, Acute, Lymphoma, Non-Hodgkin, Multiple Myeloma, Hematologic Neoplasms

NCT01676961 2018-10-15

Romiplostim in Increasing Low Platelet Counts in Patients With Multiple Myeloma Receiving Chemotherapy

Phase 2 Terminated

5 enrolled 4 charts

Classical hematologyPlasma cell

Multiple Myeloma, Thrombocytopenia